research-copilot 0.1.0

package/lib/skills/builtin/scientific-writing/references/professional_report_formatting.md

@@ -0,0 +1,664 @@
+# Professional Report Formatting for Scientific Documents
+
+This reference guide covers professional formatting for scientific reports, technical documents, and white papers. Use the `scientific_report.sty` LaTeX style package for consistent, professional output.
+
+---
+
+## When to Use Professional Report Formatting
+
+### Use This Style For:
+
+- **Research reports** - Internal and external research summaries
+- **Technical reports** - Detailed technical documentation and analyses
+- **White papers** - Position papers and thought leadership documents
+- **Grant reports** - Progress reports and final grant reports
+- **Policy briefs** - Research-informed policy recommendations
+- **Industry reports** - Technical reports for industry audiences
+- **Internal research summaries** - Team and stakeholder communications
+- **Feasibility studies** - Technical and research feasibility assessments
+- **Project documentation** - Research project deliverables
+
+### Do NOT Use This Style For:
+
+- **Journal manuscripts** → Use `venue-templates` skill for journal-specific formatting
+- **Conference papers** → Use `venue-templates` skill for conference requirements
+- **Academic theses/dissertations** → Use institutional templates
+- **Peer-reviewed submissions** → Follow journal author guidelines
+
+**Key Distinction**: Professional report formatting prioritizes visual appeal and readability for general audiences, while journal manuscripts must follow strict publisher requirements.
+
+---
+
+## Overview of scientific_report.sty
+
+The `scientific_report.sty` package provides:
+
+| Feature | Description |
+|---------|-------------|
+| Typography | Helvetica font family for modern, professional appearance |
+| Color Scheme | Coordinated blues, greens, oranges, and purples |
+| Box Environments | Colored boxes for organizing content types |
+| Tables | Professional styling with alternating rows |
+| Figures | Consistent caption formatting |
+| Headers/Footers | Professional page headers and footers |
+| Scientific Commands | Shortcuts for p-values, effect sizes, statistics |
+
+### Basic Document Setup
+
+```latex
+\documentclass[11pt,letterpaper]{report}
+\usepackage{scientific_report}
+
+\begin{document}
+% Your content here
+\end{document}
+```
+
+**Compilation**: Use XeLaTeX or LuaLaTeX for proper Helvetica font rendering:
+```bash
+xelatex document.tex
+```
+
+---
+
+## Box Environments for Content Organization
+
+### Purpose and Usage
+
+Colored boxes help readers quickly identify different types of content. Use them strategically to highlight important information.
+
+### Available Box Environments
+
+| Environment | Color | Purpose |
+|-------------|-------|---------|
+| `keyfindings` | Blue | Major findings, discoveries, key takeaways |
+| `methodology` | Green | Methods, procedures, study design |
+| `resultsbox` | Blue-green | Statistical results, data highlights |
+| `recommendations` | Purple | Recommendations, action items, implications |
+| `limitations` | Orange | Limitations, cautions, caveats |
+| `criticalnotice` | Red | Critical warnings, safety notices |
+| `definition` | Gray | Definitions, notes, supplementary info |
+| `executivesummary` | Blue (shadow) | Executive summaries |
+| `hypothesis` | Light blue | Research hypotheses |
+
+### Key Findings Box
+
+Use for major findings and important discoveries:
+
+```latex
+\begin{keyfindings}[Research Highlights]
+Our analysis revealed three significant findings:
+\begin{enumerate}
+    \item Treatment A was 40% more effective than control (\pvalue{0.001})
+    \item Effect sizes were clinically meaningful (\effectsize{d}{0.82})
+    \item Benefits persisted at 12-month follow-up
+\end{enumerate}
+\end{keyfindings}
+```
+
+**Best Practices:**
+- Use sparingly (1-3 per chapter maximum)
+- Reserve for genuinely important findings
+- Include specific numbers and statistics
+- Write concisely
+
+### Methodology Box
+
+Use for highlighting methods and procedures:
+
+```latex
+\begin{methodology}[Study Design]
+This double-blind, randomized controlled trial employed a 2×2 factorial
+design. Participants (\samplesize{450}) were randomized to one of four
+conditions: (1) Treatment A, (2) Treatment B, (3) Combined A+B, or
+(4) Placebo control.
+\end{methodology}
+```
+
+**Best Practices:**
+- Summarize key methodological features
+- Use at the start of methods sections
+- Include sample size and design type
+- Keep technical but accessible
+
+### Results Box
+
+Use for highlighting specific statistical results:
+
+```latex
+\begin{resultsbox}[Primary Outcome Analysis]
+Mixed-effects regression revealed a significant treatment × time
+interaction, \effectsize{F(3, 446)}{8.72}, \psig{< 0.001},
+$\eta^2_p$ = 0.055, indicating differential improvement across
+treatment conditions over the study period.
+\end{resultsbox}
+```
+
+**Best Practices:**
+- Report complete statistical information
+- Use scientific notation commands
+- Include effect sizes alongside p-values
+- One box per major analysis
+
+### Recommendations Box
+
+Use for recommendations and implications:
+
+```latex
+\begin{recommendations}[Clinical Practice Guidelines]
+Based on our findings, we recommend:
+\begin{enumerate}
+    \item \textbf{Primary recommendation:} Implement screening protocol
+        for high-risk populations.
+    \item \textbf{Secondary recommendation:} Adjust treatment intensity
+        based on baseline severity scores.
+    \item \textbf{Monitoring:} Reassess at 3-month intervals.
+\end{enumerate}
+\end{recommendations}
+```
+
+**Best Practices:**
+- Make recommendations specific and actionable
+- Prioritize with clear labels
+- Link to supporting evidence
+- Include implementation guidance
+
+### Limitations Box
+
+Use for limitations, caveats, and cautions:
+
+```latex
+\begin{limitations}[Study Limitations]
+Several limitations should be considered:
+\begin{itemize}
+    \item \textbf{Sample:} Participants were recruited from academic
+        medical centers, limiting generalizability to community settings.
+    \item \textbf{Design:} The observational design precludes causal
+        inference about treatment effects.
+    \item \textbf{Attrition:} 15% dropout rate may introduce bias.
+\end{itemize}
+\end{limitations}
+```
+
+**Best Practices:**
+- Be honest and thorough
+- Explain implications of each limitation
+- Suggest how future research could address limitations
+- Don't over-qualify findings
+
+### Critical Notice Box
+
+Use for critical warnings or safety information:
+
+```latex
+\begin{criticalnotice}[Safety Warning]
+\textbf{Contraindication:} This intervention is contraindicated for
+patients with [condition]. Monitor for [adverse effects] and discontinue
+immediately if [symptoms] occur. Report serious adverse events to [contact].
+\end{criticalnotice}
+```
+
+**Best Practices:**
+- Reserve for genuinely critical information
+- Be clear and direct
+- Include specific actions to take
+- Provide contact information if relevant
+
+### Definition Box
+
+Use for definitions and explanatory notes:
+
+```latex
+\begin{definition}[Effect Size]
+An \textbf{effect size} is a quantitative measure of the magnitude of a
+phenomenon. Unlike significance tests, effect sizes are independent of
+sample size and allow comparison across studies. Common measures include
+Cohen's \textit{d} for mean differences and Pearson's \textit{r} for
+correlations.
+\end{definition}
+```
+
+**Best Practices:**
+- Define technical terms at first use
+- Keep definitions concise
+- Include practical interpretation guidance
+- Use for audience-appropriate terms
+
+---
+
+## Professional Table Formatting
+
+### Design Principles
+
+1. **Clean appearance**: Use `booktabs` rules (`\toprule`, `\midrule`, `\bottomrule`)
+2. **Alternating rows**: Apply `\rowcolor{tablealt}` to every other row
+3. **Clear headers**: Bold headers for column identification
+4. **Appropriate precision**: Report statistics to appropriate decimal places
+5. **Complete information**: Include sample sizes, units, and notes
+
+### Standard Data Table
+
+```latex
+\begin{table}[htbp]
+\centering
+\caption{Demographic Characteristics by Treatment Group}
+\label{tab:demographics}
+\begin{tabular}{@{}lcc@{}}
+\toprule
+\textbf{Characteristic} & \textbf{Treatment} & \textbf{Control} \\
+ & (\samplesize{225}) & (\samplesize{225}) \\
+\midrule
+Age, years, \meansd{M}{SD} & \meansd{42.3}{12.5} & \meansd{43.1}{11.8} \\
+\rowcolor{tablealt} Female, n (\%) & 128 (56.9) & 121 (53.8) \\
+Education, years, \meansd{M}{SD} & \meansd{14.2}{2.8} & \meansd{14.5}{2.6} \\
+\rowcolor{tablealt} Baseline score, \meansd{M}{SD} & \meansd{52.4}{15.3} & \meansd{51.8}{14.9} \\
+\bottomrule
+\end{tabular}
+\figurenote{No significant differences between groups at baseline (all \textit{p} > .10).}
+\end{table}
+```
+
+### Results Table with Significance Indicators
+
+```latex
+\begin{table}[htbp]
+\centering
+\caption{Treatment Effects on Primary and Secondary Outcomes}
+\label{tab:results}
+\begin{tabular}{@{}lcccc@{}}
+\toprule
+\textbf{Outcome} & \textbf{Treatment} & \textbf{Control} & \textbf{Effect} & \textbf{p} \\
+ & \meansd{M}{SD} & \meansd{M}{SD} & \textbf{(d)} & \\
+\midrule
+Primary outcome & \meansd{68.4}{14.2} & \meansd{54.1}{15.8} & 0.95\sigthree & <.001 \\
+\rowcolor{tablealt} Secondary A & \meansd{4.2}{1.1} & \meansd{3.5}{1.2} & 0.61\sigtwo & .003 \\
+Secondary B & \meansd{22.8}{5.4} & \meansd{21.2}{5.1} & 0.31\sigone & .042 \\
+\rowcolor{tablealt} Secondary C & \meansd{8.9}{2.3} & \meansd{8.5}{2.4} & 0.17\signs & .285 \\
+\bottomrule
+\end{tabular}
+
+\vspace{0.5em}
+{\small \siglegend}
+\end{table}
+```
+
+### Comparison Table with Quality Ratings
+
+```latex
+\begin{table}[htbp]
+\centering
+\caption{Evidence Summary by Study}
+\label{tab:evidence}
+\begin{tabular}{@{}llccc@{}}
+\toprule
+\textbf{Study} & \textbf{Design} & \textbf{N} & \textbf{Quality} & \textbf{Evidence} \\
+\midrule
+Smith et al. (2024) & RCT & 450 & \qualityhigh & \evidencestrong \\
+\rowcolor{tablealt} Jones et al. (2023) & Cohort & 1,250 & \qualitymedium & \evidencemoderate \\
+Chen et al. (2023) & Case-control & 320 & \qualitymedium & \evidencemoderate \\
+\rowcolor{tablealt} Lee et al. (2022) & Cross-sectional & 890 & \qualitylow & \evidenceweak \\
+\bottomrule
+\end{tabular}
+\end{table}
+```
+
+---
+
+## Figure and Caption Styling
+
+### Caption Formatting
+
+The style package automatically formats captions with:
+- Blue, bold figure labels
+- Gray descriptive text
+- Centered alignment with margins
+
+### Standard Figure
+
+```latex
+\begin{figure}[htbp]
+\centering
+\includegraphics[width=0.9\textwidth]{../figures/results_comparison.png}
+\caption{Comparison of Outcome Scores by Treatment Condition and Time Point}
+\label{fig:results}
+\end{figure}
+```
+
+### Figure with Source Attribution
+
+```latex
+\begin{figure}[htbp]
+\centering
+\includegraphics[width=0.85\textwidth]{../figures/trend_analysis.png}
+\caption{Trends in Key Metrics Over the Study Period}
+\figuresource{Study data collected January--December 2024}
+\label{fig:trends}
+\end{figure}
+```
+
+### Figure with Explanatory Note
+
+```latex
+\begin{figure}[htbp]
+\centering
+\includegraphics[width=0.8\textwidth]{../figures/conceptual_model.png}
+\caption{Conceptual Model of Hypothesized Relationships}
+\figurenote{Solid arrows indicate primary pathways; dashed arrows indicate moderated relationships. Numbers represent standardized coefficients.}
+\label{fig:model}
+\end{figure}
+```
+
+---
+
+## Color Palette and Visual Hierarchy
+
+### Color Usage Guidelines
+
+| Color | Use For | Avoid Using For |
+|-------|---------|-----------------|
+| Primary Blue | Headers, important findings | Warnings, cautions |
+| Science Green | Methods, positive results | Negative findings |
+| Orange | Cautions, limitations | Positive findings |
+| Red | Critical warnings | Routine content |
+| Purple | Recommendations | Findings, methods |
+| Gray | Definitions, notes | Key findings |
+
+### Visual Hierarchy
+
+1. **Executive summary boxes** (shadow effect) - Most prominent
+2. **Colored content boxes** - High prominence for key content
+3. **Tables with color** - Medium prominence for data
+4. **Body text** - Standard prominence
+5. **Definition boxes** - Lower prominence for supplementary info
+
+### Accessibility Considerations
+
+- Color palette is designed to be distinguishable for common color vision deficiencies
+- All boxes have both color AND structural indicators (borders, backgrounds)
+- Text maintains sufficient contrast ratios
+- Don't rely solely on color to convey meaning
+
+---
+
+## Typography Guidelines
+
+### Font Specifications
+
+| Element | Font | Size | Color |
+|---------|------|------|-------|
+| Body text | Helvetica | 11pt | Dark gray (#424242) |
+| Chapter titles | Helvetica Bold | Huge | Primary blue (#003366) |
+| Section headings | Helvetica Bold | Large | Primary blue (#003366) |
+| Subsections | Helvetica Bold | large | Secondary blue (#4A90E2) |
+| Subsubsections | Helvetica Bold | normalsize | Dark gray (#424242) |
+
+### Spacing
+
+- Line spacing: 1.15 (for readability)
+- Paragraph spacing: 0.5em between paragraphs
+- Page margins: 1 inch on all sides
+
+### Best Typography Practices
+
+1. **Consistency**: Use the same formatting for similar elements
+2. **Hierarchy**: Use visual weight to indicate importance
+3. **Readability**: Adequate spacing and contrast
+4. **Professionalism**: Avoid mixing fonts or excessive formatting
+
+---
+
+## Scientific Notation Commands Reference
+
+### Statistical Reporting
+
+| Command | Output | When to Use |
+|---------|--------|-------------|
+| `\pvalue{0.023}` | *p* = 0.023 | Report p-values |
+| `\psig{< 0.001}` | ***p*** = < 0.001 | Significant p-values (bold) |
+| `\CI{0.45}{0.72}` | 95% CI [0.45, 0.72] | Confidence intervals |
+| `\effectsize{d}{0.75}` | d = 0.75 | Effect sizes |
+| `\samplesize{250}` | *n* = 250 | Sample sizes |
+| `\meansd{42.5}{8.3}` | 42.5 ± 8.3 | Mean with SD |
+
+### Significance Indicators
+
+| Command | Output | Meaning |
+|---------|--------|---------|
+| `\sigone` | * | p < 0.05 |
+| `\sigtwo` | ** | p < 0.01 |
+| `\sigthree` | *** | p < 0.001 |
+| `\signs` | ns | not significant |
+| `\siglegend` | Full legend | For table footnotes |
+
+### Quality and Evidence Ratings
+
+| Command | Output | Meaning |
+|---------|--------|---------|
+| `\qualityhigh` | **HIGH** (green) | High quality |
+| `\qualitymedium` | **MEDIUM** (orange) | Moderate quality |
+| `\qualitylow` | **LOW** (red) | Low quality |
+| `\evidencestrong` | **Strong** (green) | Strong evidence |
+| `\evidencemoderate` | **Moderate** (orange) | Moderate evidence |
+| `\evidenceweak` | **Weak** (red) | Weak evidence |
+
+### Trend Indicators
+
+| Command | Symbol | Meaning |
+|---------|--------|---------|
+| `\trendup` | ▲ (green) | Increasing trend |
+| `\trenddown` | ▼ (red) | Decreasing trend |
+| `\trendflat` | → (gray) | Stable/no change |
+
+---
+
+## Complete LaTeX Examples
+
+### Executive Summary Example
+
+```latex
+\chapter*{Executive Summary}
+\addcontentsline{toc}{chapter}{Executive Summary}
+
+\begin{executivesummary}[Report Highlights]
+This report presents findings from a comprehensive study of [topic]
+involving \samplesize{450} participants across 12 research sites.
+The research addressed [key question] using [methodology].
+\end{executivesummary}
+
+\subsection*{Key Findings}
+
+\begin{keyfindings}
+\begin{enumerate}
+    \item The primary intervention demonstrated a large effect
+          (\effectsize{d}{0.82}, \psig{< 0.001}).
+    \item Benefits were maintained at 12-month follow-up.
+    \item Cost-effectiveness analysis supports implementation.
+\end{enumerate}
+\end{keyfindings}
+
+\subsection*{Recommendations}
+
+\begin{recommendations}
+Based on these findings, we recommend:
+\begin{enumerate}
+    \item Implement the intervention in [settings].
+    \item Train practitioners using the standardized protocol.
+    \item Monitor outcomes using the validated measures.
+\end{enumerate}
+\end{recommendations}
+```
+
+### Methods Section Example
+
+```latex
+\chapter{Methods}
+
+\begin{methodology}[Study Overview]
+This randomized controlled trial employed a parallel-group design with
+1:1 allocation to intervention or control conditions. The study was
+conducted across 12 sites between January 2023 and December 2024.
+\end{methodology}
+
+\section{Participants}
+
+A total of \samplesize{450} participants were enrolled. Eligibility
+criteria were:
+
+\begin{itemize}
+    \item Age 18--65 years
+    \item Diagnosis of [condition] per [criteria]
+    \item No contraindications to [intervention]
+\end{itemize}
+
+Table~\ref{tab:participants} presents participant characteristics.
+
+\begin{limitations}[Recruitment Challenges]
+Recruitment was slower than anticipated due to [reasons]. The final
+sample was 10% below target, which may affect statistical power for
+secondary analyses.
+\end{limitations}
+```
+
+### Results Section Example
+
+```latex
+\chapter{Results}
+
+\section{Primary Outcome}
+
+\begin{resultsbox}[Primary Analysis]
+Mixed-effects regression revealed a significant treatment effect,
+\effectsize{F(1, 448)}{42.18}, \psig{< 0.001}, with a large effect
+size (\effectsize{d}{0.82}). The treatment group showed significantly
+greater improvement (\meansd{16.4}{5.2} points) compared to control
+(\meansd{8.1}{4.8} points).
+\end{resultsbox}
+
+Figure~\ref{fig:primary} illustrates the treatment effects over time.
+
+\begin{figure}[htbp]
+\centering
+\includegraphics[width=0.9\textwidth]{../figures/primary_outcome.png}
+\caption{Primary Outcome Scores by Treatment Group and Time Point}
+\figurenote{Error bars represent 95\% confidence intervals.}
+\label{fig:primary}
+\end{figure}
+
+\section{Secondary Outcomes}
+
+Results for secondary outcomes are presented in Table~\ref{tab:secondary}.
+```
+
+### Discussion Section Example
+
+```latex
+\chapter{Discussion}
+
+\section{Summary of Findings}
+
+\begin{keyfindings}[Main Conclusions]
+\begin{enumerate}
+    \item The intervention was highly effective (primary hypothesis
+          \highlight{supported})
+    \item Effects were clinically meaningful and durable
+    \item Evidence strength: \evidencestrong
+\end{enumerate}
+\end{keyfindings}
+
+\section{Limitations}
+
+\begin{limitations}
+Several limitations warrant consideration:
+\begin{itemize}
+    \item The sample was predominantly [demographic], limiting
+          generalizability.
+    \item Attrition was higher in the control group (18\% vs. 12\%).
+    \item Self-report measures may be subject to response bias.
+\end{itemize}
+\end{limitations}
+
+\section{Implications}
+
+\begin{recommendations}[Research Implications]
+\begin{enumerate}
+    \item Replicate in diverse populations
+    \item Investigate mechanisms of change
+    \item Test implementation strategies
+\end{enumerate}
+\end{recommendations}
+
+\begin{recommendations}[Practice Implications]
+\begin{enumerate}
+    \item Adopt the intervention in [settings]
+    \item Train providers using standardized protocols
+    \item Monitor fidelity and outcomes
+\end{enumerate}
+\end{recommendations}
+```
+
+---
+
+## Checklist: Professional Report Quality
+
+Before finalizing your report, verify:
+
+### Formatting
+- [ ] Using `scientific_report.sty` package
+- [ ] Compiled with XeLaTeX or LuaLaTeX
+- [ ] Helvetica font rendering correctly
+- [ ] Colors displaying properly
+
+### Content Organization
+- [ ] Executive summary present and complete
+- [ ] Key findings highlighted in boxes
+- [ ] Methods clearly described
+- [ ] Results properly formatted with statistics
+- [ ] Limitations acknowledged
+- [ ] Recommendations are specific and actionable
+
+### Tables
+- [ ] All tables have captions and labels
+- [ ] Alternating row colors applied
+- [ ] Significance indicators explained
+- [ ] Numbers formatted consistently
+
+### Figures
+- [ ] All figures have captions and labels
+- [ ] Sources attributed where appropriate
+- [ ] Resolution sufficient for printing (300 DPI)
+- [ ] Referenced in text
+
+### Statistical Reporting
+- [ ] P-values reported appropriately
+- [ ] Effect sizes included
+- [ ] Confidence intervals where relevant
+- [ ] Sample sizes stated
+
+### Professional Appearance
+- [ ] Consistent formatting throughout
+- [ ] No orphaned headers or widows
+- [ ] Page breaks at appropriate locations
+- [ ] References complete and formatted
+
+---
+
+## Resources
+
+### Files in This Skill
+
+- `assets/scientific_report.sty` - The LaTeX style package
+- `assets/scientific_report_template.tex` - Complete report template
+- `assets/REPORT_FORMATTING_GUIDE.md` - Quick reference guide
+
+### Related Skills
+
+- `venue-templates` - For journal manuscripts and conference papers
+- `scientific-schematics` - For generating diagrams and figures
+- `generate-image` - For creating illustrations and graphics
+
+### External Resources
+
+- [LaTeX Wikibook](https://en.wikibooks.org/wiki/LaTeX) - General LaTeX reference
+- [Booktabs Package Documentation](https://ctan.org/pkg/booktabs) - Professional table styling
+- [tcolorbox Package Documentation](https://ctan.org/pkg/tcolorbox) - Colored box environments
+